ArticleBMJ open2025

Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimus-based post-transplant cyclophosphamide (Methods of T cell Depletion, MoTD trial).

Ronjon Chakraverty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.